Siver Andreas Moestue
Short biography Max 160 characters [0/160]
Dr. Siver A. Moestue earned his PhD at the Norwegian University of Science and Technology (NTNU). He is currently a postdoctoral research fellow in the Medical Imaging Laboratory, NTNU, on a personal research grant from the Norwegian Cancer Society. Trained a MSc. Pharm at the University of Oslo, he started his career as a preclinical researcher in GE Healthcare. Here, he was involved in development of molecularly targeted contrast agents for SPECT/PET, and development of the Sonazoid® microbubble. In his current research, Dr. Moestue is investigating the use of MRI and MRS in cancer therapy monitoring.
Scientific, academic and artistic work
Displaying a selection of activities. See all publications in the database
- (2013) Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer. Breast Cancer Research. volum 15 (1:R16).
- (2012) In vivo MRI and histopathological assessment of tumor microenvironment in luminal-like and basal-like breast cancer xenografts. Journal of Magnetic Resonance Imaging. volum 35 (5).
- (2012) Glycerophosphocholine (GPC) is a poorly understood biomarker in breast cancer. Proceedings of the National Academy of Science of the United States of America. volum 109 (38).
- (2012) Intravascular Targets for Molecular Contrast-Enhanced Ultrasound Imaging. International Journal of Molecular Sciences. volum 13 (6).
- (2011) MRS and MRSI guidance in molecular medicine: targeting and monitoring of choline and glucose metabolism in cancer. NMR in Biomedicine. volum 24 (6).
- (2011) Metabolic effects of signal transduction inhibition in cancer assessed by magnetic resonance spectroscopy. Molecular Oncology. volum 5 (3).
- (2011) HR MAS MR Spectroscopy in Metabolic Characterization of Cancer. Current Topics in Medicinal Chemistry. volum 11 (1).
- (2010) Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models. BMC Cancer. volum 10.
- (2009) Whole-body section fluorescence imaging - a novel method for tissue distribution studies of fluorescent substances. Contrast Media & Molecular Imaging. volum 4 (2).
- (2010) 13C HR MAS MRS reveals differences in the glucose metabolism between two breast cancer xenograft models with different gene expression pattern. International Society of Magnetic Resonance in Medicine (ISMRM) . ISMRM; Stockholm. 2010-05-01 - 2010-05-07.